Cryo Cell International (CCEL) Cash from Financing Activities (2011 - 2026)
Cryo Cell International (CCEL) posted quarterly Cash from Financing Activities of -$1.6 million for Q2 2026, down 328.59% year-over-year from $710155.0 in Q2 2025, and down 119.28% quarter-over-quarter from -$740290.0 in Q1 2026.
Cryo Cell International (CCEL) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Cash from Financing Activities for 16 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 328.59% year-over-year to -$1.6 million; the TTM figure through May 2026 stood at -$6.8 million (down 125.98% YoY), while the FY2025 annual figure was -$4.7 million, down 384.64% from the prior year.
- Cash from Financing Activities retreated to -$1.6 million in Q2 2026 per CCEL's latest filing, from -$740290.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $8.7 million in Q3 2022 and bottomed at -$5.6 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$556275.6 across 5 years, with a median of -$855093.5 in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 1217.08% in 2022 and fell as far as 1476.04% in 2022.
- Cryo Cell International's Cash from Financing Activities stood at -$5.6 million in 2022, then soared by 72.32% to -$1.5 million in 2023, then soared by 56.0% to -$677821.0 in 2024, then sank by 38.29% to -$937340.0 in 2025, then slumped by 73.18% to -$1.6 million in 2026.
- Business Quant data shows CCEL's Cash from Financing Activities at -$1.6 million in Q2 2026, -$740290.0 in Q1 2026, and -$937340.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -704.00 Mn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -1.18 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -76.90 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | -270.19 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | -41.45 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | -189.49 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -76.57 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | -33.21 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | -24.67 Mn |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | -1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -1.62 Mn |
| May 31, 2026 | -1.62 Mn |
| Feb 28, 2026 | -740,290.00 |
| Feb 28, 2026 | -740,290.00 |
| Nov 30, 2025 | -937,340.00 |
| Nov 30, 2025 | -937,340.00 |
| Aug 31, 2025 | -3.51 Mn |
| Aug 31, 2025 | -3.51 Mn |
| May 31, 2025 | 710,155.00 |
| May 31, 2025 | 710,155.00 |
| Feb 28, 2025 | -1.00 Mn |
| Feb 28, 2025 | -1.00 Mn |
| Nov 30, 2024 | -677,821.00 |
| Nov 30, 2024 | -677,821.00 |
| Aug 31, 2024 | -2.04 Mn |
| Aug 31, 2024 | -2.04 Mn |
| May 31, 2024 | 1.20 Mn |
| May 31, 2024 | 1.20 Mn |
| Feb 29, 2024 | 538,959.00 |
| Feb 29, 2024 | 538,959.00 |